Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

被引：0
|
作者：
Weich, Natalia [1 ]
Ferri, Cristian [1 ]
Beatriz Moiraghi, Elena [2 ]
Nelida Bengio, Raquel Maria [3 ]
Amanda Giere, Isabel [4 ]
Pavlovsky, Carolina [4 ]
Larripa, Irene [5 ]
Freya Fundia, Ariela [1 ]
机构：
[1] CONICET Acad Nacl Med, IMEX, Lab Hematol Genet, Buenos Aires, DF, Argentina
[2] HOSP RAMOS MEJIA, Buenos Aires, DF, Argentina
[3] IIHEMA Acad Nacl Med, Buenos Aires, DF, Argentina
[4] FUNDALEU, Buenos Aires, DF, Argentina
[5] Conicet Acad Nacl Med, IMEX, Lab Hematol Genet, Caba, Argentina
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Significance of TP53 Codon 72 in a Cohort of Egyptian Chronic Lymphocytic Leukemia Patients
    Saleh, Layla
    Elnagar, Fatma El-Zahraa
    Emarah, Ziad
    Eissa, Noha
    Abdel-Ghaffar, Hasan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S282 - S283
  • [12] Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia
    Xu, Wei
    Li, Jian-Yong
    Wu, Yu-Jie
    Yu, Hui
    Shen, Qiu-Dan
    Li, Li
    Fan, Lei
    Qiu, Hong-Xia
    LEUKEMIA RESEARCH, 2008, 32 (07) : 1071 - 1077
  • [13] ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis
    Zheng, Q.
    Wu, H.
    Yu, Q.
    Kim, D. H.
    Lipton, J. H.
    Angelini, S.
    Soverini, S.
    Vivona, D.
    Takahashi, N.
    Cao, J.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (02): : 127 - 134
  • [14] ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysis
    Q Zheng
    H Wu
    Q Yu
    D H (Dennis) Kim
    J H Lipton
    S Angelini
    S Soverini
    D Vivona
    N Takahashi
    J Cao
    The Pharmacogenomics Journal, 2015, 15 : 127 - 134
  • [15] ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients
    van der Holt, Bronno
    Van den Heuvel-Eibrink, Marry M.
    Van Schaik, Ron H. N.
    van der Heiden, Ilse P.
    Wiemer, Erik A. C.
    Vossebeld, Paula J. M.
    Lowenberg, Bob
    Sonneveld, Pieter
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (05) : 427 - 439
  • [16] Molecular alterations in the TP53 gene of peripheral blood cells of patients with chronic myeloid leukemia
    Peller, S
    Yona, R
    Kopilova, Y
    Prokocimer, M
    Goldfinger, N
    Uysal, A
    Karabulut, HG
    Tukun, A
    Bokesoy, I
    Tuncman, G
    Rotter, V
    GENES CHROMOSOMES & CANCER, 1998, 21 (01): : 2 - 7
  • [17] Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms
    Ma, Qiang
    Liu, Yan
    Zhao, Hong
    Guo, Yixian
    Sun, Wanling
    Hu, Ronghua
    HEMATOLOGY, 2024, 29 (01)
  • [18] Prognostic Significance of TP53 Mutations and Single Nucleotide Polymorphisms in Acute Myeloid Leukemia: A case Series and Literature Review
    Zeichner, Simon Blechman
    Alghamdi, Sarah
    Elhammady, Gina
    Poppiti, Robert John
    Castellano-Sanchez, Amilcar
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (04) : 1603 - 1609
  • [19] Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia
    Hui He
    Jiye Yin
    Xi Li
    Yu Zhang
    Xiaojing Xu
    Ming Zhai
    Juan Chen
    Chenyue Qian
    Honghao Zhou
    Zhaoqian Liu
    European Journal of Clinical Pharmacology, 2015, 71 : 293 - 302
  • [20] Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia
    He, Hui
    Yin, Jiye
    Li, Xi
    Zhang, Yu
    Xu, Xiaojing
    Zhai, Ming
    Chen, Juan
    Qian, Chenyue
    Zhou, Honghao
    Liu, Zhaoqian
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (03) : 293 - 302
12345